Movatterモバイル変換


[0]ホーム

URL:


Journal Logo

Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.

Export to

PRECLINICAL REPORTS

Activation of GPR120 promotes the metastasis of breast cancer through the PI3K/Akt/NF-κB signaling pathway

Zhang, Meijuan; Qiu, ShengFeng

Author Information

Department of Laboratory Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu Province 210029, China

Correspondence to ShengFeng Qiu, BSc, Jiangsu Provincial Women and Children Health Hospital, Jiangdong North Road 368#, Nanjing 210029, China Tel: +86 025 6830 8026; fax: +86 025 8622 7420; e-mail:[email protected]

Received April 24, 2018

Accepted October 26, 2018

Anti-Cancer Drugs30(3):p 260-270, March 2019. |DOI:10.1097/CAD.0000000000000716

Abstract

G-protein-coupled receptor 120 (GPR120) plays an important role in regulating lipid and glucose metabolism as a long-chain unsaturated fatty acid receptor. However, it has been widely accepted that omega-3 polyunsaturated fatty acids are not dependent on the activation of GPR120 to exert anti-tumor activity. Therefore, the role of GPR120 in tumor development has not yet been elucidated. Here we show that activation of GPR120 promotes angiogenesis and metastasis in human breast cancer. We show that activation of GPR120 in human breast cancer cells can promote vascular endothelial growth factor, interleukin-8 secretion, cell migration, and epithelial mesenchymal transition. Similarly, phosphatidylinositide 3-kinases/RAC-alpha serine/threonine-protein kinase/nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway is involved in GPR120 activation-induced cell migration and epithelial mesenchymal transition in breast cancer cells. In conclusion, our findings indicate that GPR120 acts as a cancer-promoting receptor in the development of breast cancer. Therefore, GPR120 is expected to be a potential new target for cancer therapy.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Log InAccess through Ovid
Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.


[8]ページ先頭

©2009-2025 Movatter.jp